Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

SHE:301060 Revenue

Shanghai Labway Clinical Laboratory had revenue of 304.48M CNY in the quarter ending June 30, 2026, a decrease of -25.46%. This brings the company's total for the last twelve months to 1.28B, down -20.64% year-over-year. In the year 2025, Shanghai Labway Clinical Laboratory had annual revenue of 1.45B, down -16.88%. That makes Shanghai Labway Clinical Laboratory the 17,749th largest company in the world by revenue and 3,233rd in China.

• Revenue (ttm): 1.28B
• Revenue Growth: -20.64%
• P/S Ratio: 3.16
• Revenue / Employee: 1.03M
• Employees: 1,245
• Market Cap: 4.19B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Medical Diagnostic Services 738.24M 51.0%
• Sales of in Vitro Diagnostic Products 709.04M 49.0%
• Unallocated Other Business 761.58K 0.1%

Fiscal year ended Dec 31, 2025 See the full SHE:301060 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.45B	-294.15M	-16.88%
Dec 31, 2024	1.74B	67.81M	4.05%
Dec 31, 2023	1.67B	-2.52B	-60.13%
Jan 1, 2023	4.20B	2.42B	136.14%
Jan 1, 2022	1.78B	540.14M	43.62%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error